A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

The generic drug contains cefovecin sodium, the same active ingredient as Convenia (Zoetis), which was approved by the FDA in ...

By Sooji Nam Click here for updates on this story SAN FRANCISCO (KPIX) -- With the FDA recently rejecting a drug application ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

The antibody-based drug Andembry is the first to target factor XIIa, a protein responsible for swelling in people with this ...